Anil Bhatta1, Lin Yao1, Zhimin Xu2, Haroldo A Toque1, Jijun Chen1, Reem T Atawia1, Abdelrahman Y Fouda1,2, Zsolt Bagi2,3, Rudolf Lucas1,2, Ruth B Caldwell2,4,5, Robert W Caldwell1,2. 1. Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. 2. Vascular Biology Centre, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. 3. Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. 4. Department of Cell Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. 5. Veterans Administration Medical Centre, Augusta, GA 30912, USA.
Abstract
AIMS: Elevation of arginase activity has been linked to vascular dysfunction in diabetes and hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L-arginine depletion. Excessive arginase activity also can drive L-arginine metabolism towards the production of ornithine, polyamines, and proline, promoting proliferation of vascular smooth muscle cells and collagen formation, leading to perivascular fibrosis. We hypothesized that there is a specific involvement of arginase 1 expression within the vascular endothelial cells in this pathology. METHODS AND RESULTS: To test this proposition, we used models of type 2 diabetes and metabolic syndrome. Studies were performed using wild type (WT), endothelial-specific arginase 1 knockout (EC-A1-/-) and littermate controls(A1con) mice fed high fat-high sucrose (HFHS) or normal diet (ND) for 6 months and isolated vessels exposed to palmitate-high glucose (PA/HG) media. Some WT mice or isolated vessels were treated with an arginase inhibitor, ABH [2-(S)-amino-6-boronohexanoic acid. In WT mice, the HFHS diet promoted increases in body weight, fasting blood glucose, and post-prandial insulin levels along with arterial stiffening and fibrosis, elevated blood pressure, decreased plasma levels of L-arginine, and elevated L-ornithine. The HFHS diet or PA/HG treatment also induced increases in vascular arginase activity along with oxidative stress, reduced vascular NO levels, and impaired endothelial-dependent vasorelaxation. All of these effects except obesity and hypercholesterolemia were prevented or significantly reduced by endothelial-specific deletion of arginase 1 or ABH treatment. CONCLUSION: Vascular dysfunctions in diet-induced obesity are prevented by deletion of arginase 1 in vascular endothelial cells or arginase inhibition. These findings indicate that upregulation of arginase 1 expression/activity in vascular endothelial cells has an integral role in diet-induced cardiovascular dysfunction and metabolic syndrome. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Elevation of arginase activity has been linked to vascular dysfunction in diabetes and hypertension by a mechanism involving decreased nitric oxide (NO) bioavailability due to L-arginine depletion. Excessive arginase activity also can drive L-arginine metabolism towards the production of ornithine, polyamines, and proline, promoting proliferation of vascular smooth muscle cells and collagen formation, leading to perivascular fibrosis. We hypothesized that there is a specific involvement of arginase 1 expression within the vascular endothelial cells in this pathology. METHODS AND RESULTS: To test this proposition, we used models of type 2 diabetes and metabolic syndrome. Studies were performed using wild type (WT), endothelial-specific arginase 1 knockout (EC-A1-/-) and littermate controls(A1con) mice fed high fat-high sucrose (HFHS) or normal diet (ND) for 6 months and isolated vessels exposed to palmitate-high glucose (PA/HG) media. Some WT mice or isolated vessels were treated with an arginase inhibitor, ABH [2-(S)-amino-6-boronohexanoic acid. In WT mice, the HFHS diet promoted increases in body weight, fasting blood glucose, and post-prandial insulin levels along with arterial stiffening and fibrosis, elevated blood pressure, decreased plasma levels of L-arginine, and elevated L-ornithine. The HFHS diet or PA/HG treatment also induced increases in vascular arginase activity along with oxidative stress, reduced vascular NO levels, and impaired endothelial-dependent vasorelaxation. All of these effects except obesity and hypercholesterolemia were prevented or significantly reduced by endothelial-specific deletion of arginase 1 or ABH treatment. CONCLUSION: Vascular dysfunctions in diet-induced obesity are prevented by deletion of arginase 1 in vascular endothelial cells or arginase inhibition. These findings indicate that upregulation of arginase 1 expression/activity in vascular endothelial cells has an integral role in diet-induced cardiovascular dysfunction and metabolic syndrome. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: K Sutton-Tyrrell; A Newman; E M Simonsick; R Havlik; M Pahor; E Lakatta; H Spurgeon; P Vaitkevicius Journal: Hypertension Date: 2001-09 Impact factor: 10.190
Authors: Hongtao Zhao; Joy Joseph; Henry M Fales; Edward A Sokoloski; Rodney L Levine; Jeannette Vasquez-Vivar; B Kalyanaraman Journal: Proc Natl Acad Sci U S A Date: 2005-04-11 Impact factor: 11.205
Authors: Xiu-Fen Ming; Christine Barandier; Hema Viswambharan; Brenda R Kwak; François Mach; Lucia Mazzolai; Daniel Hayoz; Jean Ruffieux; Sandro Rusconi; Jean-Pierre Montani; Zhihong Yang Journal: Circulation Date: 2004-11-29 Impact factor: 29.690
Authors: H Li; C J Meininger; J R Hawker; T E Haynes; D Kepka-Lenhart; S K Mistry; S M Morris; G Wu Journal: Am J Physiol Endocrinol Metab Date: 2001-01 Impact factor: 4.310
Authors: Dan E Berkowitz; Ron White; Dechun Li; Khalid M Minhas; Amy Cernetich; Soonyul Kim; Sean Burke; Artin A Shoukas; Daniel Nyhan; Hunter C Champion; Joshua M Hare Journal: Circulation Date: 2003-09-29 Impact factor: 29.690
Authors: Jaume Padilla; Makenzie L Woodford; Guido Lastra-Gonzalez; Vanesa Martinez-Diaz; Shumpei Fujie; Yan Yang; Alexandre M C Lising; Francisco I Ramirez-Perez; Annayya R Aroor; Mariana Morales-Quinones; Thaysa Ghiarone; Adam Whaley-Connell; Luis A Martinez-Lemus; Michael A Hill; Camila Manrique-Acevedo Journal: Endocrinology Date: 2019-12-01 Impact factor: 4.736
Authors: Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla Journal: Hypertension Date: 2020-08-24 Impact factor: 10.190
Authors: R William Caldwell; Paulo C Rodriguez; Haroldo A Toque; S Priya Narayanan; Ruth B Caldwell Journal: Physiol Rev Date: 2018-04-01 Impact factor: 37.312